VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Nightstar Therapeutics
Nightstar Therapeutics
acquired
IPO
Biopharmaceutical Manufacturer
Basic Information
Nightstar is a biopharmaceutical company focused on developing gene therapies for retinal dystrophies.
NightstaRx Limited
London,England,United Kingdom
15~50 people
January 01, 2013
https://www.biogen.com/
enquiries@nightstartx.com